BerGenBio ASA (LTS:0RU5) Total Long-Term Assets : kr1.25 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BerGenBio ASA Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. BerGenBio ASA's Total Long-Term Assets for the quarter that ended in Dec. 2024 was kr1.25 Mil.

BerGenBio ASA Total Long-Term Assets Historical Data

The historical data trend for BerGenBio ASA's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Total Long-Term Assets Chart

BerGenBio ASA Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

Get a 7-Day Free Trial

2.33

1.19

0.04

0.43

1.25

BerGenBio ASA Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Long-Term Assets	Get a 7-Day Free Trial															0.43	0.33	0.22	0.12	1.25

BerGenBio ASA Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

BerGenBio ASA Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BerGenBio ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (LTS:0RU5) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

BGBIO:Norway 7BG0:Germany

Address

Nygardsgaten 114, Bergen, NOR, 5008

Website

https://www.bergenbio.com

BerGenBio ASA is a clinical-stage biopharmaceutical company developing drugs for aggressive diseases, including drug resistant and metastatic cancers and respiratory disease. Its product, bemcentinib (BGB324), is a selective, potent, oral small molecule AXL inhibitor that has been tested in a various indications including NSCLC, AML and severe respiratory infections.

BerGenBio ASA Headlines

No Headlines